LIF and prostate cancer: This mechanism is arbitrated by castration-induced ZBTB46 (a transcription factor that is pivotal for prostate cancer metastasis) and inhibiting the ZBTB46-LIF pathway could potentially inhibit the development of castration resistance and neuroendocrine differentiation after medical or surgical castration [37].